ref_name,rx_name,iso_name,section,assay_name,potency_type,potency,cumulative_count,potency_upper_limit,potency_lower_limit,potency_unit,date_added
Sasi22,Nirmatrelvir,Wuhan-Hu-1,Figure 3 and table S4,FRET,IC50,9,1,10000,0.1,nM,2022-11-08
Sasi22,Nirmatrelvir,3CLpro:N142L,Figure 3 and table S4,FRET,IC50,85,1,10000,0.1,nM,2022-11-08
Sasi22,Nirmatrelvir,3CLpro:E166M,Figure 3 and table S4,FRET,IC50,218,1,10000,0.1,nM,2022-11-08
Sasi22,Nirmatrelvir,3CLpro:Q189E,Figure 3 and table S4,FRET,IC50,173,1,10000,0.1,nM,2022-11-08
Sasi22,Nirmatrelvir,3CLpro:Q189I,Figure 3 and table S4,FRET,IC50,38,1,10000,0.1,nM,2022-11-08
Sasi22,Nirmatrelvir,3CLpro:Q192T,Figure 3 and table S4,FRET,IC50,151,1,10000,0.1,nM,2022-11-08
